Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Minas, A. Papaioannou, P. Mystridou, E. Karetsi, P. Georgoulias, N. Liakos, S. Pournaras, K. Gourgoulianis, K. Kostikas (Larissa, Greece). Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype?. Eur Respir J 2010; 36: Suppl. 54, 1306

Member's Comments

No comment yet.

Related content which might interest you: Coexistence of cardiovascular diseases in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Metabolic syndrome in patients with stable COPD Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Metabolic syndrome and chronic diseases in COPD Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Is metabolic syndrome a significant comorbidity in mustard lung patients? Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Clinical differences of COPD patients with and without metabolic syndrome Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Is there a strong relationship between COPD and cardiovascular diseases? Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 Prevalence of self reported physician diagnosed asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome Source: Annual Congress 2012 - Epidemiology of asthma Year: 2012 Comparison between COPD and non-COPD patients with established cardiovascular diseases: A profiling of respiratory symptoms and functional status Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010